1. Home
  2. OCGN vs STKL Comparison

OCGN vs STKL Comparison

Compare OCGN & STKL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ocugen Inc.

OCGN

Ocugen Inc.

HOLD

Current Price

$1.60

Market Cap

387.3M

Sector

Health Care

ML Signal

HOLD

Logo SunOpta Inc.

STKL

SunOpta Inc.

HOLD

Current Price

$4.72

Market Cap

454.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCGN
STKL
Founded
2013
1973
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
387.3M
454.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
OCGN
STKL
Price
$1.60
$4.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$7.00
$7.75
AVG Volume (30 Days)
6.2M
1.1M
Earning Date
03-04-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$5,370,000.00
$792,436,000.00
Revenue This Year
$35.88
$13.49
Revenue Next Year
N/A
$7.13
P/E Ratio
N/A
$110.28
Revenue Growth
14.26
11.95
52 Week Low
$0.52
$3.32
52 Week High
$1.96
$7.68

Technical Indicators

Market Signals
Indicator
OCGN
STKL
Relative Strength Index (RSI) 51.41 66.81
Support Level $1.57 $3.60
Resistance Level $1.70 $5.01
Average True Range (ATR) 0.14 0.22
MACD -0.02 0.07
Stochastic Oscillator 22.45 79.08

Price Performance

Historical Comparison
OCGN
STKL

About OCGN Ocugen Inc.

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

Share on Social Networks: